GLP-1 receptor agonist (Wegovy) The active ingredient in Wegovy is semaglutide , which is a GLP-1 receptor agonist
Presented for research literature review only Koeplinger KA et al
When Should You Stop Semaglutide or Tirzepatide
Peptide Therapy at a Glance EXPECTED RESULTS Enhanced cellular repair, improved hormone balance, increased energy, better sleep, fat loss, and immune support TREATMENT LENGTH Varies daily or weekly administration over 412+ weeks depending on protocol RECOMMENDED SESSIONS Ongoing use for 13 months, with regular monitoring and dose adjustments WHERE IT TREATS Systemic works at the cellular level to support immune, endocrine, metabolic, and neurological systems WHAT IT TREATS Hormone imbalance, weight gain, poor recovery, fatigue, inflammation, aging, low libido, immune dysfunction, and neurological decline TREATMENT COST $350 $1,200/month (depending on the type of peptide and dosing protocol) What is Peptide Therapy